Stock market news

Seligdar

Seligdar's RAS loss for 2024 amounted to ₽7.6 billion against a profit of ₽14.4 billion in the previous year. Revenue increased by 13.7% to ₽1.66 billion against ₽1.46 billion a year earlier.

United Medical Group

United Medical Group's IFRS net profit for 2024 amounted to €104.1 million, down 0.1% from €104.2 million in the previous year. Revenue declined 6.2% to €253.7 million from €270.5 million a year earlier.

VSMPO-AVISMA Corporation

VSMPO-AVISMA's RAS net profit for 2024 amounted to ₽10.03 billion, down twofold from ₽23.5 billion in the previous year. Revenue decreased by 3.6% to ₽100 billion against ₽103.7 billion a year earlier.

MOSTOTREST

Mostotrest's RAS net profit for 2024 amounted to ₽0.546 billion, down 3.3 times from ₽1.81 billion in the previous year. Revenue rose 3.1% to ₽4.02 billion against ₽3.9 billion a year earlier.

Novolipetsk Iron and Steel Works

Novolipetsk Steel's RAS net profit for 2024 amounted to ₽52.4 billion, down 4 times from ₽221.5 billion in the previous year. Revenue rose 5.5% to ₽737.5 billion against ₽698.9 billion a year earlier.

UGC

Yuzhuralzoloto's RAS loss for 2024 amounted to ₽7.18 billion, up 31.7% from ₽5.45 billion in the previous year. Revenue declined 26.3% to ₽25 billion against ₽33.9 billion a year earlier.

SPB Exchange

SPB Exchange's RAS loss for 2024 amounted to ₽10.7 billion, down 49 times from ₽525.8 billion in the previous year. Trading and investment income rose 44.6% to ₽1.2 billion against ₽0.83 billion a year earlier. Services and commissions revenue declined 5.5 times to ₽0.111 billion.

Kazanorgsintez

Kazanorgsintez's IFRS net profit for 2024 amounted to ₽10.6 billion, down 33.3% from ₽15.9 billion in the previous year. Revenue rose 5.3% to ₽104.9 billion from ₽99.6 billion a year earlier.

MOEX Group (Moscow Exchange)

Trading volume over the weekend of March 29-30, 2025, on Moscow Exchange amounted to ₽21.5 billion, up 43%. More than 115,000 investors concluded over 550,000 transactions. Greatest trading activity was concentrated in shares of Sberbank, Lukoil, Gazprom, T-technologies and Rosneft.

Artgen

Artgen's RAS net profit for 2024 amounted to ₽265.45 million, up 8.5% from ₽244.62 million in the previous year. Revenue rose 61.7% to ₽119.86 million against ₽74.14 million a year earlier.